Skip to main content

and
  1. Article

    Open Access

    Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study

    Efficacy and safety of the fixed ratio combination of insulin degludec and liraglutide (IDegLira) has been largely documented. However, long-term data are limited. This study aimed at describing persistence in...

    Chiara Di Loreto, Roberta Celleno, Debora Pezzuto, Franca Ambrosi in Diabetes Therapy (2024)

  2. Article

    Open Access

    Correction to: Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

    Chiara Di Loreto, Viviana Minarelli, Giovanni Nasini in Diabetes Therapy (2022)

  3. Article

    Open Access

    Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

    To complement results of the SUSTAIN program, this study assessed effectiveness and safety of once weekly subcutaneous semaglutide in people with type 2 diabetes (T2D) managed under routine care.

    Chiara Di Loreto, Viviana Minarelli, Giovanni Nasini in Diabetes Therapy (2022)

  4. Article

    Open Access

    Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety

    Real-world evidence on the effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. We have therefore evaluated the effectiveness and safety of IDeg, including impact on met...

    Paola Ponzani, Cesare Berra, Alessandra Di Lelio, Paola Del Sindaco in Diabetes Therapy (2020)

  5. Article

    Open Access

    Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety

    Real-world evidence on effectiveness and safety of insulin degludec (IDeg) in patients with diabetes is a priority. The aim of the study was to evaluate patterns of use and the long-term effectiveness and safe...

    Paola Ponzani, Cesare Berra, Alessandra Di Lelio, Paola Del Sindaco in Diabetes Therapy (2018)